OneSource Specialty Pharma Limited appointed M/s B S R & Co LLP as its statutory auditors for a term of 5 years during its 19th Annual General Meeting held on September 23, 2026. The appointment was approved by shareholders alongside other key resolutions.

The virtual meeting, which commenced at 5:00 pm IST and concluded at 6:02 pm IST, saw the adoption of financial statements for the fiscal year ended March 31, 2026. Neeraj Sharma, Chief Executive Officer and Managing Director, briefed attendees on strategic updates and the company’s annual performance.

Statutory auditor appointment details

Shareholders approved the appointment of M/s B S R & Co LLP, Chartered Accountants, to hold office from the conclusion of the 19th AGM until the conclusion of the 24th AGM. This constitutes a 5-year tenure. The firm has a strength of over 4,000 personnel and 170 partners, serving several listed companies including those in the Pharma and Life Sciences sector.

Key resolutions transacted

The agenda included the re-appointment of Neeraj Sharma as a retiring director and approval for additional remuneration payable to the Managing Director. Additionally, shareholders voted on commission for non-executive independent directors and material related party transactions with Strides Pharma Science Ltd and Strides Pharma Inc, USA.

Governance and compliance details

The meeting was chaired by Arun Kumar, Chairperson of the Board. Trisha A, Company Secretary and Compliance Officer, confirmed compliance with the Companies Act, 2013, and SEBI regulations. The Auditor's Report for both consolidated and standalone financial statements contained no qualifications or adverse remarks.

Voting was conducted electronically via the National Securities Depository Limited (NSDL) platform. Remote e-voting was open from September 18, 2026, to September 22, 2026. Nidhi Shree J, Partner at M/s. V Sreedharan & Associates, served as the scrutinizer. Results were scheduled for declaration within two working days.

Attendance and participation

A total of 81 shareholders holding 34,604,605 shares attended the meeting. The quorum was confirmed by NSDL prior to proceedings. Key management personnel, including Chief Financial Officer Anurag Bhagania, participated from the corporate office in Bengaluru. Several independent directors joined via video conference, including Debarati Sen, Dr. Claudio Albrecht, Colin Bond, Dr. Rashmi Barbhaiya, Vijay Karwal, and Bharat D Shah.

Representatives from the outgoing auditors, Deloitte Haskins & Sells, and proposed auditors, B S R & Co LLP, were present.

OneSource Specialty Pharma issued an addendum to the notice of its 19th Annual General Meeting scheduled for September 23, 2026. The company disclosed additional information regarding material related party transactions with Strides Pharma Science Limited and Strides Pharma Inc, USA.

The addendum forms an integral part of the original AGM notice dated July 24, 2026. It specifically addresses Item No. 6 and Item No. 7 of the agenda, which seek shareholder approval for these transactions. Strides Pharma Inc is a wholly owned subsidiary of Strides Pharma Science Limited.

Compliance Disclosures

The Audit Committee has reviewed the certificates provided by the Chief Executive Officer and Chief Financial Officer of the listed entity. These reviews were conducted in accordance with Industry Standards pertaining to Related Party Transactions (RPTs).

The meeting will be held via Video Conferencing at 5:00 pm IST. The company uploaded the addendum to its website and submitted it to BSE Limited and National Stock Exchange of India Limited for records.